Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Premium Health vs SexyMD

By GLP-1 ScorecardUpdated

Premium HealthFactor scores not reassessed.
Site position #393

Lower score

SexyMDFactor scores not reassessed.
Site position #354

Higher score

Score comparison

SexyMD has the higher recorded score — 60.3/100 to 58.8/100, but only just.

SexyMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Every price SexyMD advertises is a 48-week commitment rate, and the month-to-month figures behind them are $50 higher for semaglutide and $70 higher for tirzepatide. Premium Health is close behind and may still be the better fit — see the factor split below.

Before you choose

Before comparing the headline prices, the Premium Health review and the SexyMD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Premium Health vs The Edit and Renlo Health vs SexyMD compare each of them with another graded program, and the list of alternatives to Premium Health ranks the programs closest to Premium Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the SkinnyRx review covers one graded close to these two, at 60.5/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valuePremium Health +13
51
38
Dose & formulationPremium Health +8
72
64
Clinical oversightSexyMD +18
55
73
Labs & monitoringPremium Health +1
53
52
FulfillmentSexyMD +16
69
85
Contract termsSexyMD +12
55
67
Premium Health · top barSexyMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricPremium HealthSexyMD
WeighScore58.8/10060.3/100
GradeCC
Site position#393#354
Semaglutide$275/mo (all doses, compounded)$149/mo (4-week plan; $99/mo on 48-week plan; compounded)
Tirzepatide$445/mo (all doses, compounded)$199/mo (4-week plan; $129/mo on 48-week plan; compounded)
CoverageCoverage not published47 states (all except Arkansas, Mississippi and New Jersey)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Premium Health

Site position #393 · C

Factor scores not reassessed.

FDAWarning letter issued to Premium Health Management Inc. dba Premium Health in February 2026. See the FDA warning-letter database.

Strengths

  • All-inclusive membership covers medication, supplies, shipping, and provider visits
  • Names three licensed pharmacy partners (Hallandale, Red Rock, Strive)
  • Compounded with Vitamin B12 or B6 to aid tolerance
  • Free consultation and HIPAA-compliant telehealth via Doxy.me

What to consider

  • The LegitScript seal ID published for this provider, #8148613, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass
  • Compounded medications are not FDA-approved
  • Higher base pricing than many compounded competitors ($275/$445)
  • High-dose tiers cost extra ($100-$150/mo)
  • FDA issued Premium Health Management Inc. dba Premium Health a warning letter in February 2026; the letter is public in FDA's warning-letter database
SexyMD

Site position #354 · C

Factor scores not reassessed.

Strengths

  • Publishes an exact exclusion list — all states except Arkansas, Mississippi and New Jersey — rather than a nationwide claim
  • States both compounding classes in the Terms, so the class question is answered even though the pharmacy is not named
  • Names the prescribing entity and the professional corporation behind it
  • Sells two microdose products with their own published price tables rather than only as a discount tier

What to consider

  • Every headline price is the 48-week commitment rate: $99 against a four-week figure of $149, and $129 against $199, with an asterisk that resolves to no footnote
  • The same footer, on every page, says both that the service is available in all 50 states and that it is available in all states except three
  • The two microdose products publish identical prices for their 4-, 8- and 12-week plans, in the same table format that carries real tiers elsewhere
  • The microdose page contradicts itself on dosing frequency inside a single page
  • Three unsourced and mutually inconsistent social-proof figures appear across the homepage, the footer and the product pages
  • The checkout claims two patient counts for a single day that together exceed the total the site's own badge claims
  • No pharmacy is named, and what the price includes is never itemized on any product page

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard